Effect of warnings in a medical journal on the use of orphenadrine.
Gjerden
Pål
P
Bramness
Jørgen G
JG
Slørdal
Lars
L
D000978:Antiparkinson Agents / Q000009:adverse effects; D018680:Cholinergic Antagonists / Q000009:adverse effects; D004345:Drug Industry; D004363:Drug Utilization; D006801:Humans; D009966:Orphenadrine / Q000009:adverse effects; D010506:Periodicals as Topic; D010818:Practice Patterns, Physicians'
D000978:Antiparkinson Agents; D018680:Cholinergic Antagonists; D009966:Orphenadrine